SureTrader
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

They will have to be a reverse split

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
headshrink3 Member Profile
 
Followed By 2
Posts 98
Boards Moderated 0
Alias Born 04/24/13
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/5/2016 4:15:27 PM
RXi Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference "PR Newswire (US)" - 1/26/2016 7:02:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/19/2016 4:08:26 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/13/2016 12:58:30 PM
RXi Pharmaceuticals Announces the Initiation of a Phase 2 Trial in Dermatology with Samcyprone for Cutaneous Warts "PR Newswire (US)" - 12/21/2015 7:02:00 AM
RXi Pharmaceuticals to Present at the 8th Annual Biotech Showcase 2016 "PR Newswire (US)" - 12/14/2015 7:02:00 AM
RXI PHARMACEUTICALS "InvestorsHub NewsWire" - 11/16/2015 5:10:29 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/12/2015 5:37:42 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/12/2015 4:11:24 PM
RXi Pharmaceuticals Reports Third Quarter 2015 Financial Results and Business Highlights "PR Newswire (US)" - 11/12/2015 4:05:00 PM
RXi Pharmaceuticals Announces the Initiation of a Phase 1/2 Trial in Ophthalmology with RXI-109 for Retinal Scarring "PR Newswire (US)" - 11/5/2015 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/4/2015 5:27:10 PM
RXi Pharmaceuticals to Webcast Third Quarter 2015 Financial Results on Thursday, November 12, 2015 "PR Newswire (US)" - 10/29/2015 7:02:00 AM
RXi Pharmaceuticals Announces Compound Selection for Cosmetic Product Development with its Novel Self-delivering RNAi Platfor... "PR Newswire (US)" - 10/21/2015 7:02:00 AM
RXi Pharmaceuticals Announces Remarkable and Positive Results with its Novel Self-Delivering RNAi Platform: Potent Reduction ... "PR Newswire (US)" - 10/20/2015 7:02:00 AM
RXi Pharmaceuticals Announces Positive Interim Results in Phase 2a Dermatology Program with RXI-109 "PR Newswire (US)" - 10/15/2015 7:02:00 AM
RXi Pharmaceuticals to Present at Premier Scientific Plastic Surgery Meeting "PR Newswire (US)" - 10/12/2015 7:02:00 AM
RXi Pharmaceuticals to Present at 14th Annual BIO Investor Forum "PR Newswire (US)" - 10/7/2015 7:02:00 AM
RXi Pharmaceuticals Bolsters Protection for its Novel Self-Delivering RNAi Platform with Notice of Allowance from USPTO "PR Newswire (US)" - 10/5/2015 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/29/2015 8:57:24 AM
RXi Pharmaceuticals to Present at Dawson James Securities Growth Stock Conference "PR Newswire (US)" - 9/29/2015 7:02:00 AM
RXi Pharmaceuticals Granted Patent in China for Lead Clinical Candidate RXI-109 "PR Newswire (US)" - 9/28/2015 7:02:00 AM
Biotechnology Equities under the Scanner -- Gilead Sciences, Aeterna Zentaris, RXi Pharma, BioCryst Pharma, and Kite Pharma "PR Newswire (US)" - 9/18/2015 9:10:00 AM
RXi Pharmaceuticals to Present at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment Conference "PR Newswire (US)" - 9/15/2015 7:02:00 AM
RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications "PR Newswire (US)" - 9/8/2015 7:02:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist